The Underregulation of Carcinogen Exposure
Scholar calls for Congress to empower regulators to limit exposure to cancer-causing chemicals.
Are Psychedelics Safe Enough for Recreational Use?
Policymakers should account for the relatively low risks of psychedelics use when deciding how to regulate them.
Global Perspectives on Psychedelics Regulation
Experts discuss the benefits and drawbacks of existing regulatory frameworks for psychedelics.
Branching Regulatory Paths and Dead Ends in Psychedelics
The convergence of current psychedelics regulatory pathways may bring benefits and new challenges.
FDA’s Minimal Authority over Dietary Supplements
Scholars urge Congress to give FDA more power to regulate dietary supplements.
Cutting Corners on COVID-19 Treatments?
Scholars analyze FDA’s emergency use authorizations during the COVID-19 pandemic.
Regulating Junk Food Marketing
Scholars critique the scarcity of regulation surrounding food marketing to children.
Regulating Physician-Assisted Death
Scholar analyzes the relation between federal regulation and assisted death initiatives.
Intermediaries in the Drug-Price War
Experts debate the role of pharmacy benefit managers in rising U.S. drug prices.
Cleaning Up “Clean” Food Labeling
Scholars propose avenues to improving the regulation of clean food labels.
How Patents Contribute to High Drug Prices
Patents covering drugs selected for Medicare price negotiation show how patents influence drug prices.